Literature DB >> 28967519

Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells.

Adriana Forero1, Katherine Fenstermacher2, Nicholas Wohlgemuth2, Andrew Nishida1, Victoria Carter1, Elise A Smith1, Xinxia Peng1, Melissa Hayes2, Doreen Francis3, John Treanor3, Juliet Morrison1, Sabra L Klein2, Andrew Lane4, Michael G Katze5, Andrew Pekosz6.   

Abstract

The host innate immune response to influenza virus is a key determinant of pathogenic outcomes and long-term protective immune responses against subsequent exposures. Here, we present a direct contrast of the host responses in primary differentiated human nasal epithelial cell (hNEC) cultures following infection with either a seasonal H3N2 influenza virus (WT) or the antigenically-matched live-attenuated vaccine (LAIV) strain. Comparison of the transcriptional profiles obtained 24 and 36h post-infection showed that the magnitude of gene expression was greater in LAIV infected relative to that observed in WT infected hNEC cultures. Functional enrichment analysis revealed that the antiviral and inflammatory responses were largely driven by type III IFN induction in both WT and LAIV infected cells. However, the enrichment of biological pathways involved in the recruitment of mononuclear leukocytes, antigen-presenting cells, and T lymphocytes was uniquely observed in LAIV infected cells. These observations were reflective of the host innate immune responses observed in individuals acutely infected with influenza viruses. These findings indicate that cell-intrinsic type III IFN-mediated innate immune responses in the nasal epithelium are not only crucial for viral clearance and attenuation, but may also play an important role in the induction of protective immune responses with live-attenuated vaccines.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epithelial cells; Host response; Inflammation; Influenza virus; Interferon; Live-attenuated vaccine

Mesh:

Substances:

Year:  2017        PMID: 28967519      PMCID: PMC5647870          DOI: 10.1016/j.vaccine.2017.09.058

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  39 in total

1.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

2.  The R35 residue of the influenza A virus NS1 protein has minimal effects on nuclear localization but alters virus replication through disrupting protein dimerization.

Authors:  Erin N Lalime; Andrew Pekosz
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

Review 3.  Innate immunity of the sinonasal cavity and its role in chronic rhinosinusitis.

Authors:  Murugappan Ramanathan; Andrew P Lane
Journal:  Otolaryngol Head Neck Surg       Date:  2007-03       Impact factor: 3.497

4.  Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.

Authors:  Mark D Wareing; Ashley B Lyon; Bao Lu; Craig Gerard; Sally R Sarawar
Journal:  J Leukoc Biol       Date:  2004-07-07       Impact factor: 4.962

5.  mRNA for genes associated with antigen presentation are expressed by human middle meatal epithelial cells in culture.

Authors:  Andrew P Lane; Bahman Saatian; Xiao-Ying Yu; Ernst William Spannhake
Journal:  Laryngoscope       Date:  2004-10       Impact factor: 3.325

6.  Protective efficacy of intranasally administered bivalent live influenza vaccine and immunological mechanisms underlying the protection.

Authors:  Hyun-Mi Pyo; Yan Zhou
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

7.  Systems biology of vaccination for seasonal influenza in humans.

Authors:  Helder I Nakaya; Jens Wrammert; Eva K Lee; Luigi Racioppi; Stephanie Marie-Kunze; W Nicholas Haining; Anthony R Means; Sudhir P Kasturi; Nooruddin Khan; Gui-Mei Li; Megan McCausland; Vibhu Kanchan; Kenneth E Kokko; Shuzhao Li; Rivka Elbein; Aneesh K Mehta; Alan Aderem; Kanta Subbarao; Rafi Ahmed; Bali Pulendran
Journal:  Nat Immunol       Date:  2011-07-10       Impact factor: 25.606

8.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

9.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

Review 10.  Sialic acid tissue distribution and influenza virus tropism.

Authors:  Urban Kumlin; Sigvard Olofsson; Ken Dimock; Niklas Arnberg
Journal:  Influenza Other Respir Viruses       Date:  2008-09       Impact factor: 4.380

View more
  14 in total

1.  A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.

Authors:  Junyu Chen; Pui Wang; Lunzhi Yuan; Liang Zhang; Limin Zhang; Hui Zhao; Congjie Chen; Xijing Wang; Jinle Han; Yaode Chen; Jizong Jia; Zhen Lu; Junping Hong; Zicen Lu; Qian Wang; Rirong Chen; Ruoyao Qi; Jian Ma; Min Zhou; Huan Yu; Chunlan Zhuang; Xiaohui Liu; Qiangyuan Han; Guosong Wang; Yingying Su; Quan Yuan; Tong Cheng; Ting Wu; Xiangzhong Ye; Tianying Zhang; Changgui Li; Jun Zhang; Huachen Zhu; Yixin Chen; Honglin Chen; Ningshao Xia
Journal:  Sci Bull (Beijing)       Date:  2022-05-26       Impact factor: 20.577

2.  Influenza A Virus Reassortment Is Limited by Anatomical Compartmentalization following Coinfection via Distinct Routes.

Authors:  Mathilde Richard; Sander Herfst; Hui Tao; Nathan T Jacobs; Anice C Lowen
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

3.  The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.

Authors:  Nicholas Wohlgemuth; Yang Ye; Katherine J Fenstermacher; Hsuan Liu; Andrew P Lane; Andrew Pekosz
Journal:  Vaccine       Date:  2017-10-25       Impact factor: 3.641

4.  Wood Smoke Exposure Alters Human Inflammatory Responses to Viral Infection in a Sex-Specific Manner. A Randomized, Placebo-controlled Study.

Authors:  Meghan E Rebuli; Adam M Speen; Elizabeth M Martin; Kezia A Addo; Erica A Pawlak; Ellen Glista-Baker; Carole Robinette; Haibo Zhou; Terry L Noah; Ilona Jaspers
Journal:  Am J Respir Crit Care Med       Date:  2019-04-15       Impact factor: 21.405

5.  Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.

Authors:  Harrison Powell; Hsuan Liu; Andrew Pekosz
Journal:  Vaccine       Date:  2021-05-11       Impact factor: 4.169

Review 6.  Interferon-stimulated genes: new platforms and computational approaches.

Authors:  Richard Green; Reneé C Ireton; Michael Gale
Journal:  Mamm Genome       Date:  2018-07-07       Impact factor: 3.224

7.  Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus.

Authors:  Sean A Nelson; Andrea J Sant
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

8.  Identification of H3N2 NA and PB1-F2 genetic variants and their association with disease symptoms during the 2014-15 influenza season.

Authors:  Deena R Blumenkrantz; Thomas Mehoke; Kathryn Shaw-Saliba; Harrison Powell; Nicholas Wohlgemuth; Hsuan Liu; Elizabeth Macias; Jared Evans; Mitra Lewis; Rebecca Medina; Justin Hardick; Lauren M Sauer; Andrea Dugas; Anna DuVal; Andrew P Lane; Charlotte Gaydos; Richard Rothman; Peter Thielen; Andrew Pekosz
Journal:  Virus Evol       Date:  2021-06-04

9.  A Live-Attenuated Equine Influenza Vaccine Stimulates Innate Immunity in Equine Respiratory Epithelial Cell Cultures That Could Provide Protection From Equine Herpesvirus 1.

Authors:  Lila M Zarski; Wendy E Vaala; D Craig Barnett; Fairfield T Bain; Gisela Soboll Hussey
Journal:  Front Vet Sci       Date:  2021-06-10

Review 10.  Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.

Authors:  Stephanie Ascough; Suzanna Paterson; Christopher Chiu
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.